Introducing proprietary Derma product to 32,000+ healthcare providers
PRINCETON, N.J., April 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has signed a new multi-year supply agreement with one of the nation's largest group purchasing organizations, MedAssets Supply Chain Systems, a MedAssets company (Nasdaq: MDAS). The 3-year agreement, with an effective date of June 1, 2008, will help to introduce MEDIHONEY(TM) Wound & Burn Dressing with Active Leptospermum Honey to the organization's growing customer base, and will provide these customers with a group discounted rate. Currently, MedAssets serves more than 125 health systems, 2,500 hospitals and 30,000 non-acute care healthcare providers. On an annual basis, MedAssets manages on behalf of its customers, an excess of $15 billion in supplies and services.
This supply agreement for specialty advanced wound care products features Derma Sciences' MEDIHONEY, line of dressings with Active Leptospermum Honey for managing a wide variety of wounds and burns. In July, the FDA gave its initial clearance of MEDIHONEY, and the product was launched last fall. Since then, another clearance for a line extension has been granted and a third is pending. Sales have rapidly increased, and over 20 clinical abstracts on the use of the product have been accepted at various wound conferences in 2008.
Marta V. Beile RN, a director of clinical supply chain for MedAssets'
materials management division, decided it would be highly beneficial for
MedAssets customers to carve out a "specialty" products agreement for this
exciting new product. Beile stated, "It makes sense to provide our wound
|SOURCE Derma Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved